Because of you, science is saving lives.🔬💡
Your generosity has made it possible for our investigators pioneer new treatments for pneumonia, diabetes, and respiratory disease. And it’s empowering young scientists through hands-on research and mentorship in our education programs.
Right now, every donation is being matched 1:1 by Melanie and Richard Lundquist through year-end. Together, we can accelerate the discoveries that shape a healthier tomorrow.
Support tomorrow's cures and double your impact this year-end: https://t.co/MnvCVR4y5c
#Philanthropy #Giving #DonorImpact #SocialGood #SupportScience #FuelOurMission #GivingBack #MakeADifference
This week marks Fungal Disease Awareness Week to highlight the growing public health threat posed by fungal infections.🦠🧫
Per @CDCgov, many fungal diseases are an emerging global health threat — often under-recognized, frequently misdiagnosed, and increasingly resistant to available treatments.
At The Lundquist Institute, we are committed to advancing translational research that addresses these challenges — from studying the molecular mechanisms of fungal pathogens to developing novel tools for early detection and treatment. Our recent stories showcase that commitment and the impact of our science on public health. 🧬🔬
Join us in raising awareness: Early detection matters, proper treatment saves lives. Support our work and other critical research at TLI: https://t.co/10LBdIg78a.
#FungalWeek25 #PublicHealth #TheLundquistInstitute #FungalDisease #DiseasePrevention #Innovation #Biomedical
Meet TLI’s philanthropic champions, Melanie and Richard Lundquist, whose deep-rooted passion and visionary support have powered transformational change at TLI: fueling innovation through researcher-focused funding, upgrading infrastructure, and advancing life‑saving biomedical research.
“When you provide funding with intention, your money works in perpetuity. Like a stone thrown into a pond, there is a ripple effect,” said Melanie Lundquist. “You have the ability to remove obstacles to care, and to save lives.”
Read more about their legacy and heartfelt connection to TLI's mission: https://t.co/xEopNUMXIn #philanthropy #donorimpact
Honored to welcome
@SenBillCassidy to @the_lundquist. I showed him
@IbrahimLab3, where we study host–pathogen interactions, develop immunotherapies for mucormycosis, and advance vaccines against drug-resistant infections. Grateful for his support of biomedical research.
In this interview with @Contagion_Live, TLI Investigator @IbrahimLab3 delves deeper into how VX-01, a newly developed humanized monoclonal antibody, prevents fungal invasion of blood vessels and enhances immune response in immunocompromised patients.🔬🧬#mucormycosis #medicalbreakthroughs
Tune in: https://t.co/nFpl6qaEUU
Mucormycosis is a fungal infection that causes severe disease and fatality. “Mucormycosis usually occurs in patients who suffer from weakened immune system, such as patients with poorly controlled diabetes, cancer patients undergoing chemotherapy, and transplant patients,” says TLI Investigator Ashraf Ibrahim, PhD. 🔬🧪
Learn more about the groundbreaking antibody Dr. Ashraf Ibrahim, Dr. Yiyou Gu, and the @IbrahimLab3 team has developed that could be a promising treatment to help fight mucormycosis: https://t.co/7nYLAGX8YY
#medicalresearch #biomedicine #Immunotherapy #publications
What an incredible way to kick off 2025! We had a great time yesterday at our Town Hall Meeting where we were able to hear our new President and CEO Dr. @joewramos' vision for TLI. We're excited and grateful for Dr. Ramos' #leadership and can't wait for him to share his vision for TLI’s future with you! Stay tuned! 🔬📷📷🌎🚀
My lab has an opening for a Postdoctoral Research fellow. If you are interested in Candida auris pathogenesis and translational research, apply:
@HarborUCLA_ID , @the_lundquist
More information: https://t.co/CNIV42nSVC
@the_lundquist was pleased to welcome Dr. Johnson V. John, PhD and faculty member @TerasakiInst to campus as part of the President’s Lecture Series. He spoke to our investigators about New Forms of Biomaterials for Diabetic Wound Healing.
@the_lundquist Investigator Dr. @shaktim16 Awarded Five-Year @NIH Grant for Groundbreaking Research on Candida auris.
This five-year grant supports Dr. Singh’s cutting-edge work, which aims to unravel the complex mechanisms of C. auris virulence and explore new vaccine strategies
Applications are now open for the @GordonConf Immunology of Fungal Infections 2025! Submit your abstract now to save your spot - this popular meeting is usually oversubscribed. Link to apply here: https://t.co/YTkH75dGO6
@the_lundquist Investigator Ashraf Ibrahim, PhD, has been selected by the Medical Mycology Society of the Americas (MMSA) to receive the 2024 Billy H. Cooper Award for his continuous outstanding achievement in clinical mycology. TLI congratulates Dr Ibrahim for this high honor.
@cnobile1@Guanghua11@craiglewisennis I noticed this when I started working on C. auris mouse model back in 2017. I am glad someone looked in this and delineated this unusual phenomenon in vivo. Kudos to the whole team.